E. Ming

发表

Discontinuation of use and switching of antidepressants: influence of patient-physician communication.

L. Markson, S. Bull, X. Hu, 2002, JAMA.

Rosuvastatin safety: a comprehensive, international pharmacoepidemiology programme

R. Herings, M. Wallander, S. Johansson, 2006, Pharmacoepidemiology and drug safety.

Declining ovarian cancer rates in U.S. women in relation to parity and oral contraceptive use.

A. Whittemore, P. Hartge, E. Ming, 2000, Epidemiology.

Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate.

L. Markson, S. Bull, X. Hu, 2004, The Journal of clinical psychiatry.

Characteristics and drug utilization patterns of new users of rosuvastatin and other statins in four countries.

R. Herings, M. Wallander, S. Johansson, 2010, Minerva cardioangiologica.

Chemotherapy-induced nausea and vomiting—incidence and impact on patient quality of life at community oncology settings

E. Ming, L. Cohen, Henry X. Hu, 2007, Supportive Care in Cancer.

Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.

E. Ming, D. Potter, P. Toth, 2010, Journal of clinical lipidology.

Estimating the Prevalence of Binge Eating Disorder in a Community Sample From the United States: Comparing DSM-IV-TR and DSM-5 Criteria.

T. Wadden, E. Ming, E. Witt, 2016, The Journal of clinical psychiatry.

Safety of saxagliptin: rationale for and design of a series of postmarketing observational studies

D. Margolis, S. Kimmel, J. Roy, 2012, Pharmacoepidemiology and drug safety.

Concomitant use of statins and CYP3A4 inhibitors in administrative claims and electronic medical records databases.

J. Mckenney, E. Ming, M. Marotti, 2008, Journal of clinical lipidology.

Effectiveness of rosuvastatin compared to other statins for the prevention of cardiovascular events—a cohort study in 395 039 patients from clinical practice

Judith K Jones, E. Ming, S. Russmann, 2009, Pharmacoepidemiology and drug safety.

Pharmacoepidemiology safety study of fibrate and statin concomitant therapy.

E. Ming, S. Niemcryk, C. Enger, 2010, The American journal of cardiology.

The comparative safety of rosuvastatin: a retrospective matched cohort study in over 48 000 initiators of statin therapy

John D Seeger, E. Ming, J. Fox, 2006, Pharmacoepidemiology and drug safety.

Abstract 12055: Prevalence of Lipid Abnormalities in the United States: The National Health and Nutrition Examination Survey 2003-2006

E. Ming, D. Potter, P. Toth, 2010 .

Cardiovascular Reactivity to Work Stress Predicts Subsequent Onset of Hypertension: The Air Traffic Controller Health Change Study

Ronald C Kessler, R. Kessler, R. Rose, 2004, Psychosomatic medicine.